back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-10-02 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+750,000 vol $0.10 each |
||
| Filed 2017-10-02 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-02 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-02 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+750,000 vol $0.10 each |
||
| Filed 2017-10-02 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-02 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+375,000 vol |
||
| Filed 2017-10-02 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+375,000 vol |
||
| Filed 2017-10-02 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-01 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+375,000 vol |
375,000 | |
| Filed 2017-10-01 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$56,250
+375,000 vol $0.15 each |
||
| Filed 2017-10-01 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$56,250
+375,000 vol $0.15 each |
||
| Filed 2017-10-01 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-29 Tx date 2014-10-30 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
50 - Grant of options
|
$106,250
+425,000 vol $0.25 each |
||
| Filed 2017-09-29 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$56,250
+375,000 vol $0.15 each |
1,314,500 | |
| Filed 2017-09-29 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+750,000 vol $0.10 each |
939,500 | |
| Filed 2017-09-29 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
189,500 | ||
| Filed 2017-09-29 Tx date 2014-10-30 |
$BUX
Biomark Diagnostics Inc. |
GRG CONSULTING LTD.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
50 - Grant of options
|
$106,250
+425,000 vol $0.25 each |